Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification

Autor: Klaus Olgaard, Andreas Kjaer, Carsten H. Nielsen, Maria L. Mace, Jacob Hofman-Bang, Ewa Lewin, Eva Gravesen, Anders Nordholm, Keith A. Hruska
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
Physiology
Bone Morphogenetic Protein 7
030232 urology & nephrology
lcsh:Medicine
Gene Expression Regulation/drug effects
Gene Expression
Hyperphosphatemia
Phosphates/blood
0302 clinical medicine
Bone Density
Fibrosis
Medicine and Health Sciences
Thoracic aorta
Aorta/drug effects
lcsh:Science
Aorta
Multidisciplinary
Abdominal aorta
Vascular Calcification/drug therapy
Body Fluids
Chemistry
Blood
Connective Tissue
Physical Sciences
Anatomy
Research Article
medicine.medical_specialty
Real-Time Polymerase Chain Reaction
Blood Plasma
Calcification
Phosphates
03 medical and health sciences
medicine.artery
Internal medicine
Genetics
medicine
Animals
Bone
Vascular Calcification
Uremia
business.industry
lcsh:R
Chemical Compounds
Biology and Life Sciences
Kidneys
Renal System
X-Ray Microtomography
medicine.disease
Bone Morphogenetic Protein 7/pharmacology
Rats
Transplantation
Biological Tissue
030104 developmental biology
Endocrinology
Gene Expression Regulation
Chronic Disease
Cardiovascular Anatomy
Blood Vessels
lcsh:Q
Uremia/drug therapy
Physiological Processes
business
Developmental Biology
Zdroj: PLoS ONE
Gravesen, E, Lerche Mace, M, Nordholm, A, Hofman-Bang, J, Hruska, K, Haagen Nielsen, C, Kjær, A, Olgaard, K & Lewin, E 2018, ' Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification ', PLOS ONE, vol. 13, no. 1, e0190820 . https://doi.org/10.1371/journal.pone.0190820
PLoS ONE, Vol 13, Iss 1, p e0190820 (2018)
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0190820
Popis: Hyperphosphatemia and vascular calcification are frequent complications of chronic renal failure and bone morphogenetic protein 7 (BMP7) has been shown to protect against development of vascular calcification in uremia. The present investigation examined the potential reversibility of established uremic vascular calcification by treatment of uremic rats with BMP7. A control model of isogenic transplantation of a calcified aorta from uremic rats into healthy littermates examined whether normalization of the uremic environment reversed vascular calcification. Uremia and vascular calcification were induced in rats by 5/6 nephrectomy, high phosphate diet and alfacalcidol treatment. After 14 weeks severe vascular calcification was present and rats were allocated to BMP7, vehicle or aorta transplantation. BMP7 treatment caused a significant decrease of plasma phosphate to 1.56 ± 0.17 mmol/L vs 2.06 ± 0.34 mmol/L in the vehicle group even in the setting of uremia and high phosphate diet. Uremia and alfacalcidol resulted in an increase in aortic expression of genes related to fibrosis, osteogenic transformation and extracellular matrix calcification, and the BMP7 treatment resulted in a decrease in the expression of profibrotic genes. The total Ca-content of the aorta was however unchanged both in the abdominal aorta: 1.9 ± 0.6 μg/mg tissue in the vehicle group vs 2.2 ± 0.6 μg/mg tissue in the BMP7 group and in the thoracic aorta: 71 ± 27 μg/mg tissue in the vehicle group vs 54 ± 18 μg/mg tissue in the BMP7 group. Likewise, normalization of the uremic environment by aorta transplantation had no effect on the Ca-content of the calcified aorta: 16.3 ± 0.6 μg/mg tissue pre-transplantation vs 15.9 ± 2.3 μg/mg tissue post-transplantation. Aortic expression of genes directly linked to extracellular matrix calcification was not affected by BMP7 treatment, which hypothetically might explain persistent high Ca-content in established vascular calcification. The present results highlight the importance of preventing the development of vascular calcification in chronic kidney disease. Once established, vascular calcification persists even in the setting when hyperphosphatemia or the uremic milieu is abolished.
Databáze: OpenAIRE